Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

972 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversion.
Romero A, González V, Granell M, Matas L, Esteve A, Martró E, Rodrigo I, Pumarola T, Miró JM, Casanova A, Ferrer E, Tural C, del Romero J, Rodríguez C, Caballero E, Ribera E, Casabona J; Standardized Algorithm for Recent HIV Infections (AERIVIH) study group. Romero A, et al. Among authors: miro jm. Sex Transm Infect. 2009 Apr;85(2):106-10. doi: 10.1136/sti.2008.031864. Epub 2008 Nov 5. Sex Transm Infect. 2009. PMID: 18987013
HIV-1 infected patients older than 50 years. PISCIS cohort study.
Navarro G, Nogueras MM, Segura F, Casabona J, Miro JM, Murillas J, Tural C, Ferrer E, Jaén A, Force L, Vilaró J, García I, Masabeu A, Altés J, Esteve A, Sued O, Riera M, Clotet B, Podzamczer D, Gatell JM; PISCIS Study Group. Navarro G, et al. Among authors: miro jm. J Infect. 2008 Jul;57(1):64-71. doi: 10.1016/j.jinf.2008.05.003. Epub 2008 Jun 24. J Infect. 2008. PMID: 18572247
Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort.
Manzardo C, Esteve A, Ortega N, Podzamczer D, Murillas J, Segura F, Force L, Tural C, Vilaró J, Masabeu A, Garcia I, Guadarrama M, Ferrer E, Riera M, Navarro G, Clotet B, Gatell JM, Casabona J, Miró JM; PISCIS Investigators. Manzardo C, et al. Among authors: miro jm. Clin Microbiol Infect. 2013 Jul;19(7):646-53. doi: 10.1111/j.1469-0691.2012.03991.x. Epub 2012 Sep 12. Clin Microbiol Infect. 2013. PMID: 22967234 Free article.
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups.
Nomah DK, Reyes-Urueña J, Llibre JM, Ambrosioni J, Ganem FS, Miró JM, Casabona J. Nomah DK, et al. Among authors: miro jm. Curr HIV/AIDS Rep. 2022 Feb;19(1):17-25. doi: 10.1007/s11904-021-00596-5. Epub 2022 Feb 3. Curr HIV/AIDS Rep. 2022. PMID: 35113346 Free PMC article. Review.
[Reporting new HIV cases in Catalonia, Spain: is technical consensus feasible?].
Casabona J, Romaguera A, Almeda J, Blanch C, Caylà JA, Miró JM, Colom J; Grupo de Trabajo sobre la Declaracion del HIV (GTDHIV). Casabona J, et al. Among authors: miro jm. Gac Sanit. 2003 Jan-Feb;17(1):75-82. doi: 10.1016/s0213-9111(03)71695-1. Gac Sanit. 2003. PMID: 12605750 Free article. Spanish.
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration. del Amo J, et al. Among authors: miro jm. Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460971 Free PMC article.
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients; Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, et al. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15. Lancet. 2010. PMID: 20638118 Free PMC article.
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.
Treviño A, Aguilera A, Caballero E, Benito R, Parra P, Eiros JM, Hernandez A, Calderón E, Rodríguez M, Torres A, García J, Ramos JM, Roc L, Marcaida G, Rodríguez C, Trigo M, Gomez C, de Lejarazu RO, de Mendoza C, Soriano V; HTLV Spanish Study Group. Treviño A, et al. Virol J. 2012 Mar 23;9:71. doi: 10.1186/1743-422X-9-71. Virol J. 2012. PMID: 22444832 Free PMC article.
972 results